MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-04-0026299
Rubicon Formulations Private Limited - fmcg in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹123.25 Cr
▲ 29% YoY
Net profit · FY 2025
₹2.28 Cr
Net margin 1.8%
EBITDA · FY 2025
₹4.38 Cr
EBITDA margin 3.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹72.36 Lakh
Issued & subscribed
Open charges
₹3.67 Cr
Satisfied ₹3 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
62
Provident fund records
About Rubicon Formulations Private Limited
Data last updated:
Rubicon Formulations Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 09 December 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1999PTC122999. Its GSTIN is 27AABCR8018D1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹72.36 Lakh. It is led by directors including Pradeepkumar Chandrashekar Singh (Whole-Time Director) and Simon John Lewis (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No M – 163 MIDC Area, Aurangabad, Maharashtra, India – 431133.
As per the financials filed for FY 2025, the company reported a revenue of ₹123.25 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.28 Cr (net margin 1.8%) and EBITDA of ₹4.38 Cr (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 7% over five years.
The company has about 62 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rubicon Formulations. As per MCA filings, the company has open charges of ₹3.67 Cr and satisfied charges of ₹3 Cr on record. Court records list 27 cases involving the company, including 21 filed by the company and 6 filed against it; 15 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹69.1 Lakh; the latest was in March 2024. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Centurion Remedies Private Limited with revenue of ₹128.35 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 23 micro and small suppliers.
Rubicon Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0026299). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rubiconindia.com.
Company details
CIN U24200MH1999PTC122999
Registration Number 122999
Incorporation Date 09 December 1999
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-04-0026299
Key People
Pradeepkumar Chandrashekar Singh Whole-Time Director Simon John Lewis Whole-Time Director Ramswarup Sriram Rajoria Whole-Time Director Recognitions & Rankings of Rubicon Formulations
Contact details
Rubicon Formulations Private Limited's registered office is in Aurangabad, Maharashtra. Its website is rubiconindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No M – 163 MIDC Area, Aurangabad, Maharashtra, India – 431133
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of Rubicon Formulations Private Limited, buy the company report.
Comprehensive company report
Rubicon Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rubicon Formulations operates one associated brand: Rubicon Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in the development and manufacturing of pharmaceutical and cosmetic products. | rubiconindia.com |
Business activity
The main business activity of Rubicon Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rubicon Formulations Private Limited, buy the company report.
Financials of Rubicon Formulations Private Limited
FY 2025 filings availableRubicon Formulations Private Limited reported revenue of ₹123.25 Cr (up 29% YoY) for FY 2025.
Revenue · FY 2025
₹123.25 Cr ▲ 29%
Net profit · FY 2025
₹2.28 Cr margin 1.8%
EBITDA · FY 2025
₹4.38 Cr margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 13%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▼ 6%
5 years · compounded
▲ 3%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 29% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rubicon Formulations Private Limited, buy the company report.
Board of directors of Rubicon Formulations Private Limited
Rubicon Formulations has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeepkumar Chandrashekar Singh | Whole-Time Director | 09 Dec 1999 | 26 Years 10 Months | Current |
| Simon John Lewis | Whole-Time Director | 20 Sep 2001 | 25 Years 1 Months | Current |
| Ramswarup Sriram Rajoria | Whole-Time Director | 09 Dec 1999 | 26 Years 10 Months | Current |
| Prabhakar Vishwanath Marla | Whole-Time Director | 20 Sep 2001 | 25 Years 1 Months | Current |
Peer comparison
Rubicon Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Centurion Remedies Private Limited | ₹128.35 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India | |||
| Encore Healthcare Private Limited | ₹128.04 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Super Formulations Private Limited | ₹123.88 Cr (FY 2024) | 17.0% | Ujjain, Madhya Pradesh, India | |||
| Rubicon Formulations Private Limitedthis company | ₹123.25 Cr (FY 2025) | ₹2.28 Cr | 1.8% | 29.0% | 62 | Aurangabad, Maharashtra, India |
| Roopa Industries Limited | ₹122.98 Cr (FY 2025) | 72.0% | Kurnool, A.P, Andhra Pradesh, India | |||
| Nirchem Dyes & Chemicals Private Limited | ₹122.53 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Realcade Lifescience Private Limited | ₹122.35 Cr (FY 2025) | 8.0% | Kadi, Gujarat, India |
To see the full peer comparison of Rubicon Formulations Private Limited, buy the company report.
Auditor
Rubicon Formulations Private Limited is audited by VITHAL DESHMUKH AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VITHAL DESHMUKH AND ASSOCIATES | FY 2023 | 111600W |
Shareholding
The shareholding of Rubicon Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rubicon Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.67 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2000 | 90147488 | State Bank of India | ₹3.67 Cr | Open | |
| 21 Aug 2015 | 10612431 | Hdfc Bank Limited | ₹3 Cr | Satisfied |
To see the full charge records of Rubicon Formulations Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Rubicon Formulations Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹69.1 Lakh; the latest was in March 2024.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹69.1 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Dec 2014 | Funding round | ₹69.1 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Rubicon Formulations Private Limited has 27 court cases on record: 21 filed by Rubicon Formulations, 6 filed against it. 15 cases are pending and 12 are disposed.
Total cases
27
Filed by the company
21
Filed against the company
6
Pending
15
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 3 | 12 |
| High courts | 10 | 3 | 3 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Aurangabad, Maharashtra | Civil suit | Filed by the company against M/S MCPL Pvt Ltd and 1 other | Pending |
| District court, Aurangabad, Maharashtra | Civil suit | Filed by the company against M/S MCPL Pvt Ltd and 1 other | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Union of India and Anr and 1 other | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The State of Maharashtra Through the Principal Secretary and Others and 3 others | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company | Pending |
To see the full case history of Rubicon Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Rubicon Formulations Private Limited has 5 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| CPL Aromas Private Limited | |||
| Pranav Plastics (HP) | |||
| Ardan Plastic Industries Private Limited | |||
| Elite Precision Technologies Private Limited | |||
| Innovative Label Solutions Private Limited |
To see the full MSME payment records of Rubicon Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Rubicon Formulations Private Limited has a workforce of 62 employees on its EPFO records as of Apr 03, 2024, across 2 active EPFO establishments.
Employee count
62
Active EPFO establishments
2
Employee growth
-3.12%
GST
Rubicon Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCR8018D1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rubicon Formulations Private Limited, buy the company report.
Recent activity
Rubicon Formulations Private Limited has 4 board changes on record since 1999: 4 appointments. The latest: Prabhakar Vishwanath Marla was appointed as Whole-Time Director on 20 Sep 2001.
AGM
Rubicon Formulations Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Rubicon Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 21 Aug 2015 via Charge ID 10612431 with Hdfc Bank Limited was fully satisfied on 14 Nov 2019.
Charges
A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 21 Aug 2015 with Charge ID 10612431 was modified on 30 Oct 2015.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.00 Cr with Charge ID 10612431 was registered on 21 Aug 2015.
Charges
A charge with State Bank Of India of Rs. 3.67 Cr registered on 28 Jul 2000 with Charge ID 90147488 was modified on 21 Oct 2011.
Appointed
Prabhakar Vishwanath Marla was appointed as Whole-Time Director.
Appointed
Simon John Lewis was appointed as Whole-Time Director.
Charges
A charge with State Bank Of India amounted to Rs. 3.67 Cr with Charge ID 90147488 was registered on 28 Jul 2000.
Appointed
Pradeepkumar Chandrashekar Singh was appointed as Whole-Time Director.
Appointed
Ramswarup Sriram Rajoria was appointed as Whole-Time Director.
Incorporation
09 Dec 1999
Rubicon Formulations Private Limited was registered on 09 Dec 1999 with Roc Mumbai & aged 26 years 10 months as per MCA records.
Frequently asked questions
Rubicon Formulations is an active private limited company based in Aurangabad, Maharashtra, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 09 December 1999 (27+ years old) and is registered under CIN U24200MH1999PTC122999.
Rubicon Formulations has 4 current directors:
- Pradeepkumar Chandrashekar Singh - Whole-Time Director
- Simon John Lewis - Whole-Time Director
- Ramswarup Sriram Rajoria - Whole-Time Director
- Prabhakar Vishwanath Marla - Whole-Time Director
The latest financial statements of Rubicon Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rubicon Formulations is 27AABCR8018D1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rubicon Formulations is U24200MH1999PTC122999. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rubicon Formulations has 27 court cases on record: 21 filed by the company and 6 filed against it. 15 are pending. Most are in the district courts.
Rubicon Formulations was incorporated on 09 December 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
Rubicon Formulations has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹69.1 Lakh; the latest was in March 2024.
The peers of Rubicon Formulations by revenue are Centurion Remedies Private Limited, Encore Healthcare Private Limited, Super Formulations Private Limited, Roopa Industries Limited, Nirchem Dyes & Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prabhakar Vishwanath Marla was appointed as Whole-Time Director on 20 Sep 2001. Simon John Lewis was appointed as Whole-Time Director on 20 Sep 2001. Pradeepkumar Chandrashekar Singh was appointed as Whole-Time Director on 09 Dec 1999. Rubicon Formulations has 4 board changes on record in total.
Yes, Rubicon Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-04-0026299).
Rubicon Formulations has 5 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 23 micro and small suppliers. The latest return was filed on 29 Apr 2024.